The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF)
Luisella Cianferotti(University of Florence), Maria Luisa Brandi, Claudio Cricelli, René Rizzoli(University Hospital of Geneva), Jean-Y. Reginster(University of Liège), Ranuccio Nuti(University of Siena), J. D. Ringe(University of Cologne), John А. Kanis(Australian Catholic University)
Cited by 66
Related Papers
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
|Osteoporosis International|2018|1.8k
Assessment of fracture risk
|Osteoporosis International|2004|1.2k
A Meta-Analysis of the Association of Fracture Risk and Body Mass Index in Women
|Journal of Bone and Mineral Research|2013|470
Surgery or Surveillance for Mild Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Clinical Trial
|The Journal of Clinical Endocrinology & Metabolism|2007|406
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
|Journal of Clinical Oncology|1998|366